Antibiotics are widely used in the treatment of bacterial infections. Although known for their 19 microbicidal activity, antibiotics may also interfere with the host's immune system. Here we 20 analyzed the effects of bedaquiline (BDQ), an inhibitor of the mycobacterial ATP synthase, on 21 human macrophages. Genome-wide gene expression analysis revealed that BDQ 22 reprogramed macrophages into potent bactericidal phagocytes. We found that 1,495 genes 23 were differentially expressed in M. tuberculosis-infected macrophages incubated with the 24 drug, with an over-representation of genes involved in metabolism, lysosome biogenesis and 25 activation. BDQ treatment triggered a variety of antimicrobial defense mechanisms, including 26 nitric oxide production, phagosome-lysosome fusion, and autophagy. These effects were 27 associated with activation of transcription factor EB (TFEB), involved in the transcription of 28 lysosomal genes, resulting in enhanced intracellular killing of different bacterial species that 29 were naturally insensitive to BDQ. Thus, BDQ could be used as a host-directed therapy 30 against a wide range of bacterial infections. 31 32 33 Introduction 34 35
non-fluorescent probe that produces brightly fluorescent peptides following hydrolysis by 160 lysosomal proteases. At 18 h and 48 h post-treatment, we observed a dose-dependent 161 increase in fluorescence intensity upon treatment with BDQ (up to 5.5 times more than 162 untreated cells, p < 0.01, Figure 2F ). Together, these data demonstrate that BDQ induces 163 biogenesis of competent lysosomes.
165
Several anti-TB drugs, including INH and PZA, are known to interfere with the degradation 166 and recycling of cellular components (Kim et al., 2012) . To test whether other antibiotics 167 might have similar effects to BDQ, we treated cells with amikacin, ethambutol, kanamycin, 168 isoniazid, pyrazinamide, and rifampicin for 48 h and then incubated with LysoTracker ( Figure   169 2G). Only BDQ induced an increase in lysosome staining.
171
The capacity of BDQ to induce acidic compartments may potentiate the efficacy of other 172 drugs, whose activity is pH dependent. In vivo studies have suggested a synergistic 173 interaction between BDQ and PZA (Ibrahim et al., 2007) , and it is commonly assumed that a 174 low pH is required for PZA activity against MTB (Zhang and Mitchison, 2003) . We thus 175 infected Mφs with BDQr-MTB and treated them with BDQ and PZA. After 7 days of treatment, 176 cells were lysed and bacteria counted. PZA showed moderate bactericidal activity, with 50 177 µg/mL PZA resulting in a 36% decrease in bacterial numbers compared to untreated cells 178 ( Figure 2H ). We confirmed that the combination of PZA with BDQ was highly bactericidal on 179 MTB, leading to a 83% decrease in colony forming units using 50 µg/mL PZA. This decrease 180 was not a result of an additive effect between the two drugs, as BDQ alone had no 181 antibacterial activity, given that we used a drug-resistant strain of MTB. Thus, the potentiation 
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Autophagy delivers cytoplasmic material and organelles for lysosomal degradation and is 189 implicated in the immune response to microbes (Germic et al., 2019) . We therefore tested 190 three inhibitors of the autophagy pathway on BDQ activity: bafilomycin (BAF), which inhibits 191 the V-ATPase; chloroquine (CQ), a lysomotropic agent which prevents endosomal 192 acidification and impairs autophagosome fusion with lysosomes; and 3-methyladenine (3-MA) 193 which blocks autophagosome formation by inhibiting of the type III phosphatidylinositol 3-194 kinases (PI-3K). We infected Mφs with BDQr-MTB and incubated the cells with BDQ in the 195 presence or absence of the different inhibitors. After 2 days we analyzed LysoTracker 196 staining as a read-out of lysosome activation using flow cytometry and observed that all three 197 inhibitors prevented the increase in staining upon BDQ treatment ( Figure 3A) . autophagosomes and autolysosomes. We observed an increase of LC3B puncta per cell at 200 18 h and 48 h post-BDQ treatment using confocal microscopy ( Figure 3B-C) , which was 201 associated with the detection of lipidated LC3 (LC3-II), the form of LC3 recruited to 202 autophagosomal membranes, and with a decrease in sequestosome 1 (SQSTM1) or p62 203 levels ( Figure 3D-E) . p62 is a ubiquitin-binding scaffold protein, which is degraded upon 204 autophagy induction, and which is used as a marker of autophagic flux (Liu et al., 2016) .
205
Given we have previously observed that some mycobacterial phagosomes colocalized with 206 lysosomes in BDQ-treated cells (Figure 2E) , we tested whether BDQ promotes MTB killing,
207
independently of its bactericidal activity on MTB by autophagy. BDQ significantly reduced the 208 number of bacteria (measured by CFU) in cells infected with BDQ-resistant MTB. This effect 209 was completely inhibited by the autophagy inhibitors 3-MA and BAF ( Figure 3F) . Overall, 210 these data show BDQ activates the autophagy pathway in human Mφs and this is involved in 211 its anti-TB activity.
213

BDQ activates Mφ bactericidal functions
214
Autophagy plays numerous roles in innate immunity and in host defenses against intracellular 215 pathogens, including MTB (Gutierrez et al., 2004) . We thus asked if BDQ conferred protection 216 to bacterial infections naturally resistant to BDQ. To test this hypothesis, we infected Mφs 217 with two different bacterial species: a gram-positive bacterium, Staphylococcus aureus and a 218 gram-negative bacterium, Salmonella Typhimurium. We confirmed that these two species are 219 resistant to BDQ, even when exposed to high concentration of the drug (20 µg/mL, Figure   220 4A). However, when the cells were incubated with BDQ and then infected with S. aureus and 221 S. Typhimurium for 24 h, we observed a substantial decrease in bacterial survival rates 222 ( Figure 4B ).
224
To determine if autophagy is involved in this anti-bacterial activity we incubated the infected 225 cells with the autophagy inhibitor, 3-MA, and were unable to revert the Mφs resistance to S. 226 aureus infection upon BDQ treatment ( Figure 4C ). Mφs are professional phagocytes, which 227 have evolved a myriad of defense strategies to contain and eradicate bacteria, such as 228 radical formation, phagosome maturation, and metal accumulation (Weiss and Schaible, 229 2015). Upon incubation with BDQ, we detected an increase in the amount of NO2 -, a stable 230 derivative of NO, in the culture supernatant of Mφs, ( Figure 4D ). When the cells were treated 231 with N(G)-nitro-L-arginine methyl ester (L-NAME), an inhibitor of nitric oxide (NO) synthesis,
232
S. aureus-infected cells were unable to effectively control infection upon incubation with BDQ 233 ( Figure 4E) 
246
We investigated if BDQ might interfere with other activities of mitochondria. Conflicting reports 247 suggest that BDQ inhibits the mitochondrial ATPase (Fiorillo et al., 2016; Haagsma et al., 248 2009). We have already shown that there were no significant differences in the amount of 249 cardiolipin, an constituent of inner mitochondrial membranes, between BDQ-treated cells and 250 control cells ( Figure 1E ). We quantified changes in mitochondrial membrane potential using 251 flow cytometry in cells incubated with BDQ or with oligomycin, a positive control, which 252 hyperpolarizes the mitochondrial membrane potential, and stained with TMRM. TMRM is a 253 fluorescent cell-permeant dye that accumulates in active mitochondria with intact membrane 254 potentials. No changes were observed when Mφs were incubated with the BDQ for 6 h, 24 h 255 and 48 h ( Figure 5A ). We obtained similar results when mitochondria were stained with 256 MitoTracker® Red FM whose accumulation in mitochondria is dependent upon membrane 257 potential ( Figure 5B ). We also measured the oxygen consumption rate (OCR), and detected 
264
We thus stained for mitochondrial superoxide using the MitoSOX dye in BDQ-stimulated cells.
265
Again, we saw no difference upon antibiotic treatment ( Figure 5D ). Incubation with the 266 antioxidant glutathione (GSH) or with its precursor N-Acetyl cysteine (NAC), which prevent 267 the formation of mitochondrial ROS and reactive nitrogen species (RNS), did not prevent 268 lysosome activation and the killing of S. aureus by BDQ ( Figure 5E ). Based on these results,
269
it is unlikely that BDQ alters mitochondrial function in human Mφs. Figure 6A-B) . The activity of TFEB is regulated by phosphorylation on specific amino 280 acid residues, and its activation is mediated by calcineurin, an endogenous serine/threonine 281 phosphatase, through Ca 2+ release from the lysosome (Medina et al., 2015) . In agreement 282 with these studies, we observed an increase in intracellular Ca 2+ concentration in Mφs treated 283 for 18 h with BDQ ( Figure 6C) , and confirmed that this intracellular calcium accumulation was 284 required for antibiotic-induced TFEB translocation to the nucleus and lysosomal gene 285 expression. Upon treatment with BAPTA, a Ca 2+ chelator, TFEB remained localized in the 286 cytoplasm of BDQ-treated cells ( Figure 6D) , and we were unable to detect changes in the 287 expression of a panel of lysosomal genes, previously identified as differentially expressed in
288
Mφs incubated with BDQ ( Figure 6E ). The increased bactericidal activity against S. aureus 289 was also abrogated in the presence of BAPTA ( Figure 6F) 
448
with Treatment because we were interested in the infection-status-specific treatment effects.
449
The latter was used to extract differentially expressed genes between treated and untreated 450 samples under the infected and uninfected conditions. P-values were adjusted for multiple 451 comparisons using the Benjamini-Hochberg method producing an adjusted P-value or false-452 discovery rate (FDR).
453
Gene ontology (GO) enrichment analyses were performed using the Cytoscape app ClueGO 
489
The analysis was performed using the FlowJo software.
490
LysoTracker staining was also analyzed using a Leica TCS SP5 Confocal System. Briefly, 491 cells were washed twice with PBS after incubation with LysoTracker DND-99 (1 µM), fixed 492 with 4% paraformaldehyde for 1 h at RT, stained with DAPI (1 µg/mL, Thermo Fisher) during 493 10 min mounted on a glass slide using Fluoromount mounting medium (Thermo Fisher).
494
Quantification of LysoTracker staining was performed using Icy software. Figure 5 . Basal respiration, ATP production, maximal respiration, respiratory reserve and nonmitochondrial respiration were followed by sequential additions of oligomycin (OM, an inhibitor of the ATPase), the mitochondrial oxidative phosphorylation uncoupler FCCP, and the inhibitors of electron transport antimycin A/rotenone (Rot/AA). Error bars represent the mean ± SD of 3 technical replicates. One representative experiment (out of two) is shown.
